3 ms·
$30 is way too much, production cost of EpiPen is probably in single-digit dollars, maybe even less. That's not the point, nobody thinks EpiPen costs $300 to pr
by smsm42 10y ago
$30 is way too much, production cost of EpiPen is probably in single-digit dollars, maybe even less. That's not the point, nobody thinks EpiPen costs $300 to produce.
The system it built in a very specific and deliberate way in the US - there are patented drugs that are expensive, by design, and the pharma is supposed to finance R&D and FDA testing and so on from that money, instead of financing it through taxation, or venture investing, or other means. Now, one can claim maybe Mylan is abusing the system and the money that were supposed to finance R&D are instead financing lavish salaries or whatever. And one can claim the system should not be built at all like this but should be built other way. Maybe.
But completely ignoring the whole design and saying "ah, we've discovered it costs $30!" is useless. Yes, it actually costs even less to manufacture, way less. It's obvious. The reason why Mylan charges more is not because it costs a lot to manufacture. The reason is because that's how patented drugs market in US works. If one wants to change it, it needs to be understood how it works. It's not corruption, it's the design of the system.
- deleted 10y ago[deleted]